Framingham, MA, United States of America

Louis Michael Snyder

This inventor holds 1 USPTO granted patent. Top assignee: Quest Diagnostics Investments, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis Michael Snyder. Retrieved from https://idiyas.com/inventor/louis-michael-snyder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Louis Michael Snyder and His Anemia Diagnostic Patent

Introduction

Louis Michael Snyder is an inventor associated with Framingham, Massachusetts, and Quest Diagnostics Investments, Inc. His patent work focuses on processes and systems for identifying underlying causes of anemia.

Latest Patents

Snyder is named on one patent, titled “System for Determining an Underlying Cause of Anemia.” The invention describes automated processes and systems for assessing causes of anemia, including microcytic, normocytic, and macrocytic anemia. It also describes methods for treating an underlying cause in an individual who needs care. Snyder’s record lists 1 patent.

Career Highlights

His listed work connects diagnostic innovation with the evaluation of different forms of anemia. The patent describes an automated approach intended to support the determination of an underlying cause.

Collaborations

Snyder’s listed company is Quest Diagnostics Investments, Inc. His coworker, Jeffrey Samuel Dlott, is also associated with the patent work.

Conclusion

Louis Michael Snyder’s patent reflects an effort to apply automated systems to anemia assessment and to inform treatment of its underlying causes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…